Establishment and application of screening methods for non-agonist PPARγ ligand
Yi HUAN; Jun PENG; Yue WANG; Chun-Ming JIA; Ke WANG; Ke-Hua WANG; Zhi-Qiang FENG; Zhu-Fang SHEN.
Acta Pharmaceutica Sinica
; (12): 1658-1664, 2014.
Artículo en Zh | WPRIM | ID: wpr-251839
Documentos relacionados
[Establishment and application of screening methods for non-agonist PPARγ ligand].
Rational design of stapled helical peptides as antidiabetic PPARγ antagonists to target coactivator site by decreasing unfavorable entropy penalty instead of increasing favorable enthalpy contribution.
SetD7 (Set7/9) is a novel target of PPARγ that promotes the adaptive pancreatic ß-cell glycemic response.
Fat-specific protein 27b is regulated by hepatic peroxisome proliferator-activated receptor γ in hepatic steatosis.
Molecular cloning and characterization of olive flounder (Paralichthys olivaceus) peroxisome proliferator-activated receptor gamma.
Metabonomic profiling revealed an alteration in purine nucleotide metabolism associated with cardiac hypertrophy in rats treated with thiazolidinediones.
ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways.
Design, synthesis and biological evaluation of cajanonic acid A analogues as potent PPAR γ antagonists.
Integrative analysis reveals structural basis for transcription activation of Nurr1 and Nurr1-RXRα heterodimer.
From Prescription to Transcription: Genome Sequence as Drug Target.